The default story about a consolidating sector is that distressed assets flow upward. The startups fail, and the incumbents — the Cargills, the JBSs, the strategic ingredient houses — buy the wreckage cheaply. Our coverage of the Believer Meats estate fits that shape: a $154m plant, a $50m stalking-horse bid, an auction.
That is not what most of the 2025 deals look like.
The Good Food Institute’s full-year figures, released in February 2026, put alternative protein funding at $881m for 2025 and named five consolidation events explicitly. In three of them the buyer was another alternative protein startup — in one case a company that had itself raised $6.5m weeks earlier. And in all three, what the announcements actually describe changing hands is production capacity, cell lines, patents and regulatory filings. Revenue is barely mentioned, because in two of the three there was very little.
The three deals
| Deal | Announced | Acquirer | What the announcement says was acquired |
|---|---|---|---|
| Gourmey → Vital Meat, forming PARIMA | 15 Oct 2025 | Gourmey (cultivated duck) | 2,000-litre bioreactor capacity at Nantes, avian cell lines from ~25 years of research at Groupe Grimaud, and a combined portfolio of nine active regulatory filings |
| Fork & Good → Orbillion Bio | 30 Oct 2025 | Fork & Good (cultivated pork) | Beef cell platform, a 200-litre production run, an Abu Dhabi subsidiary, and the Luiten Food relationship |
| Bettani Farms → Stockeld Dreamery, NUMU, Hungry Planet | 3 Dec 2025 | Bettani Farms (formerly Climax Foods) | In Stockeld’s case, a full asset purchase: all IP including the patent, formulations, trademarks, and customer and distributor contracts |
None of these acquirers is a strategic. Two are pre-revenue or near it. All three deals were announced within seven weeks of each other.
What a $6.5m company buys
The Bettani case is the clearest, because both sides of it are disclosed.
Bettani Farms rebranded from Climax Foods in October 2025 and raised $6.5m. Within about six weeks it had acquired three brands: Numu, a Brooklyn dairy-free mozzarella maker founded in 2015; Hungry Planet, a plant-based meat supplier founded in 2016 and now exclusively foodservice; and Stockeld Dreamery, which had shut down in October.
Stockeld’s own numbers, given to Green Queen by co-founder Sorosh Tavakoli, explain what was for sale. The company was posting sub-$1m in revenue and expected $1.2m in 2026. It had products in roughly 500 locations. It calculated it needed $2–3m to reach profitability over about four years, with breakeven around $6m of revenue — and decided not to raise, on the grounds that even a successful version of that plan left it “subscale and vulnerable”.
So the revenue was not the asset. Tavakoli is explicit about what was: “The deal with Bettani is a full-on asset purchase, where they have acquired all of our IP, including our patent, formulations, trademarks, etc., as well as our customer and distributor contracts.”
Note also that Stockeld’s equipment went somewhere else entirely — to Danish hybrid dairy company PlanetDairy, in a separate transaction the month before, which Tavakoli describes as “centred around our equipment and sharing know-how”. A single failed company was therefore split into two sales: hardware to one buyer in Europe, intangibles to another in the US. We saw the same split in the Believer estate, where the plant and the know-how went to two separate auctions.
That is now a pattern worth naming. The plant and the paperwork have different buyers.
What PARIMA bought was a queue position
PARIMA is the deal where the regulatory asset is stated most plainly.
Gourmey’s own release says the combination gives PARIMA nine active regulatory filings across major global regions, more than 15 patent families and over 70 patent applications, and Vital Meat’s 2,000-litre bioreactor capacity in Nantes plus cell lines derived from nearly 25 years of avian cell research at Groupe Grimaud. CEO Nicolas Morin-Forest frames it directly: “This is the right moment for consolidation and scale.”
The claim PARIMA makes about the filings is the interesting one. It says it is “on course to become the first company worldwide positioned for approval of two animal species in the cultivated food sector, duck and chicken.”
Set that against what we found tracking the EFSA validation queue: novel food dossiers in Europe take years, and the queue position itself is scarce. A filing already in progress cannot be bought off a shelf and cannot be accelerated with capital. It can, however, be acquired along with the company that filed it. That makes a dossier stack a genuinely tradable asset in a way it was not five years ago, when there were no queues worth jumping.
Gourmey also states independently verified production costs below €7/kg. We are not recording that as a datapoint, and readers should not treat it as comparable to any other cost figure in this sector, because the release does not say what the €7 is measured on — biomass, finished product, or a specific cut. That omission is the single most common defect in alternative protein cost claims, and it is the reason our cost data gap piece exists.
Fork & Good bought a market position, and says so
Fork & Good’s acquisition of Orbillion is the one with the clearest commercial logic, because the two platforms were addressing different species with the same customer type.
The disclosed physical assets are modest. Fork & Good’s Jersey City pilot plant produces about seven tonnes of product a year in under 800 square feet, and Orbillion had completed a 200-litre production run for cultivated Wagyu. Neither is commercial scale. What the combination adds is geography — Orbillion brings a subsidiary in Abu Dhabi and the Luiten Food relationship with its 1,200 distribution points — and, again, regulatory optionality across four regions.
Patricia Bubner, Orbillion’s founder, is now Fork & Good’s COO, and describes the rationale in terms of contracts rather than technology: “This combination immediately expands both companies’ product range and global reach while uniting industry-seasoned talent to deliver on existing contracts.”
Fork & Good’s stated targets remain a long way from the pilot. It is aiming for $5 per lb of biomass at commercial scale, and eventually parity with commodity pork at $2 per lb. Those are targets, not achieved costs, and we record them as such.
The denominator
The reason three peer-to-peer acquisitions in seven weeks is a finding rather than a coincidence is what happened to the money.
GFI’s 2025 figures, as reported by Protein Production Technology International:
| 2025 | |
|---|---|
| Total alternative protein funding | $881m |
| Q4 2025 alone | $207m |
| Plant-based | $450m |
| Fermentation | $357m |
| Cultivated meat and seafood | $74m |
| Europe-headquartered companies | $418m |
| North America-headquartered companies | $347m |
| Cumulative since 2016 | $19.4bn ($16.7bn private, $2.7bn public) |
Cultivated meat and seafood raised $74m across the whole of 2025. That is less than half what Believer Meats alone spent building one plant. In a sector at that funding level, there is no pool of strategic buyers waiting, because the incumbents that would buy are not buying — and the only parties who understand what a cell line or a half-finished dossier is worth are the other companies holding one.
GFI’s analyst Daniel Gertner describes the mechanism without naming it as peer consolidation: “Tighter funding conditions accelerated consolidation, with restructurings, acquisitions, and portfolio rationalization becoming defining features of the market.” His five named deals include the three above, plus Prosperity Organic Foods winning the Miyoko’s Creamery assets and Meati Foods being acquired by entrepreneur Yasir Abdul and restructured as Meati Holdings.
Green Queen’s separate tracker, covering September 2024 to August 2025, counted more than 40 events — 24 acquisitions, 11 closures, four liquidations, two bankruptcies and one merger — concentrated in Europe (23) and North America (16), and overwhelmingly in plant-based companies (32 of the total) rather than fermentation (7) or cell cultivation (3). The wave has not stopped: German cultivated fat developer Cultimate Foods wound down on 12 August 2026, the day before this piece was published.
The counter-argument
Three deals is a small sample, and there is a reading in which this pattern is not new and not meaningful.
First, peer acquisition may simply be what a sector does when it has no other exit. If no strategic will buy, a merger between two struggling companies is not a strategy, it is a way of extending runway by combining two cash balances and cutting one set of overheads. GFI’s own framing includes “extend runway” as a motive. On that reading, PARIMA and Fork & Good–Orbillion are consolidation of weakness, and the capacity and dossiers being highlighted are simply the only assets available to talk about.
That is a fair challenge, and we cannot refute it from disclosures, because none of the three deals disclosed a price. Without consideration figures it is impossible to say whether a dossier stack commanded a premium or was thrown in.
Second, Bettani is arguably a different animal from the other two. It is buying brands and distribution — Numu supplies pizzerias and Whole Foods pizza bars — to give its own Caseed ingredient a route to market. That is closer to conventional roll-up logic than to capacity-and-dossier acquisition, and lumping it in with two cultivated meat deals flattens a real difference.
We think the pattern survives both objections, for one reason: in each case the acquirer identified a specific non-fungible asset — a tank in Nantes, an Abu Dhabi entity, a patent and a contract book — that it could not have built or filed for on its own timeline. That is a different act from merging two balance sheets.
What we could not establish
- No transaction value was disclosed for any of the three deals. Fork & Good–Orbillion is explicitly described as undisclosed; PARIMA and Bettani gave no figure. Every judgement here about what was “worth” acquiring rests on what the parties chose to describe, not on price.
- We could not verify Gourmey’s sub-€7/kg cost figure or its basis. The release says it is independently verified but does not name the verifier or state whether the figure is per kilogram of biomass or of finished product.
- Fork & Good’s Jersey City capacity is stated two ways in the same Green Queen report — “several tonnes of cultivated meat per year” in Bubner’s quote, and “about seven tonnes of product in less than 800 sq ft” in the surrounding text. We have used seven tonnes and flagged that “product” and “cultivated meat” may not be the same quantity.
- We could not establish whether Hungry Planet or Numu were distressed sales. Green Queen reports both acquisitions as “very recent” but gives neither financials nor deal structure, unlike Stockeld.
- The Green Queen tracker (40+) and GFI (a wave of consolidation) count different things over different windows. We have not attempted to reconcile them into a single number and readers should not treat them as additive.
What to watch
- Whether any of the acquired capacity actually runs. The Nantes 2,000-litre line and the Jersey City pilot are the two physical assets in this set. If neither is producing at higher utilisation twelve months from now, the “capacity acquisition” reading weakens considerably.
- Whether PARIMA’s nine filings survive the merger intact. Dossiers are filed by legal entities. Corporate restructuring can require refiling or at minimum notification, and a filing that loses its queue position was not the asset it appeared to be.
- Whether a price ever gets disclosed. A single disclosed consideration in a dossier-and-capacity deal would give the sector its first comparable for what a regulatory position is worth.
- Whether Bettani ships Caseed-powered product through the acquired distribution. That is the test of whether the brands were bought as a route to market or as inventory.